Schimanski CC, Bahre R, Gockel I, et al. Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4[J]. Br J Cancer, 2006,95(2):210-217.
[2]
Huang F, Geng XP. Chemokines and hepatocellular carcinoma[J]. World J Gastroenterol, 2010,16(15):1832-1836.
[3]
Albini A, Benelli R. The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation[J]. Nat Protoc, 2007,2(3):504-511.
[4]
Siegel R, Naishadham D, Jemal A. Cancer statistics[J]. CA Cancer J Clin, 2012,62(1):10-29.
[5]
Liu H, Pan Z, Li A, et al. Roles of chemokine receptor 4(CXCR4)and chemokine ligand 12(CXCL12)in metastasis of hepatocellular carcinoma cells[J]. Cell Mol Immunol, 2008,5(5):373-378.
Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T)method[J]. Nat Protoc, 2008,3(6):1101-1108.
[9]
Duda DG, Kozin SV, Kirkpatrick ND, et al. CXCL12(SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies[J]. Clin Cancer Res, 2011,17(8):2074-2080.
[10]
Patrussi L, Baldari CT. The CXCL12/CXCR4 axis as a therapeutic target in cancer and HIV-1 infection[J]. Curr Med Chem, 2011,18(4):497-512.
[11]
Sun X, Cheng G, Hao M, et al. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression[J]. Cancer Metastasis Rev, 2010,29(4):709-722.
[12]
Chu H, Zhou H, Liu Y, et al. Functional expression of CXC chemokine recepter-4 mediates the secretion of matrix metalloproteinases from mouse hepatocarcinoma cell lines with different lymphatic metastasis ability[J]. Int J Biochem Cell Biol, 2007,39(1):197-205.
